CRVL Stock Analysis: CorVel | NASDAQ
Insurance Brokers | NASDAQ, USA | Market Cap: 3.189m USD | 12M Return: -37.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 14.5M
EPS Trend: -83.0%
Rev. Trend: 99.3%
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CorVel Corporation is a U.S.-based managed care services provider that focuses on workers compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. The company applies artificial intelligence, machine learning, and natural language processing to help manage episodes of care and control related healthcare costs.
Its service portfolio spans two main areas: network solutions (including automated medical fee auditing, preferred provider management, retrospective utilization review, pharmacy services, independent medical examinations, and Medicare solutions) and patient management services (claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning). CorVel sells these services to employers, third-party administrators, insurance carriers, and government agencies involved in workers comp and property and casualty claims.
The workers compensation market in the United States is a large and regulated segment of the property and casualty insurance industry, with employers, insurers, and government entities typically paying for medical care and wage replacement for injured workers, which creates ongoing demand for cost-containment and care-coordination services like those CorVel provides.
CorVel was incorporated in 1987, is headquartered in Fort Worth, Texas, and trades on the NASDAQ under the ticker CRVL. It is classified within the Health Care sector and the Health Care Services sub-industry, and is considered a mid-cap stock with a market capitalization of approximately $2.99 billion.
- US employment growth drives workers compensation claims volume higher
- AI and machine learning automation expand claims processing margins
- Regulatory complexity boosts demand for Medicare and payment integrity services
| Net Income: 110.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 0.38 > 1.0 |
| NWC/Revenue: 24.44% < 20% (prev 20.39%; Δ 4.04% < -1%) |
| CFO/TA 0.24 > 3% & CFO 155.6m > Net Income 110.3m |
| Net Debt (-205.0m) to EBITDA (174.7m): -1.17 < 3 |
| Current Ratio: 2.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (51.3m) vs 12m ago -1.45% < -2% |
| Gross Margin: 24.29% > 18% (prev 23.42%; Δ 0.88% > 0.5%) |
| Asset Turnover: 161.2% > 50% (prev 164.0%; Δ -2.80% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.36 (Total Current Assets 462.3m - Total Current Liabilities 228.1m) / Total Assets 643.0m |
| B: 1.58 (Retained Earnings 1.01b / Total Assets 643.0m) |
| C: 0.24 (EBIT TTM 143.1m / Avg Total Assets 594.5m) |
| D: 1.58 (Book Value of Equity 394.2m / Total Liabilities 248.8m) |
| Altman-Z'' = 10.81 = AAA |
| DSRI: 0.91 (Receivables 101.3m/104.1m, Revenue 958.5m/895.6m) |
| GMI: 0.96 (GM 23.42% / 24.29%) |
| AQI: 0.76 (AQ_t 0.06 / AQ_t-1 0.09) |
| SGI: 1.07 (Revenue 958.5m / 895.6m) |
| TATA: -0.07 (NI 110.3m - CFO 155.6m) / TA 643.0m) |
| Beneish M = -3.23 (Cap -4..+1) = AA |
As of July 04, 2026, the stock is trading at USD 64.14 with a total of 189,500 shares traded. Over the past week, the price has changed by +3.82%, over one month by +12.00%, over three months by +18.62% and over the past year by -37.64%.
Current recommended Stop Loss: 61.20 (which is 4.6% or 1.3 ATR below the current price).
CorVel has no consensus analysts rating.
P/E Trailing = 29.215
P/E Forward = 23.753
P/S = 3.3271
P/B = 7.9323
Revenue TTM = 958.5m USD
EBIT TTM = 143.1m USD
EBITDA TTM = 174.7m USD
Long Term Debt = 20.7m USD (estimated: total debt 28.1m - short term 7.42m)
Short Term Debt = 7.42m USD (from shortTermDebt, last quarter)
Debt = 28.1m USD (from shortLongTermDebtTotal, last quarter) (leases 28.1m already included)
Net Debt = -205.0m USD (calculated: Debt 28.1m - CCE 233.1m)
Enterprise Value = 2.98b USD (3.19b + Debt 28.1m - CCE 233.1m)
Interest Coverage Ratio = unknown (Ebit TTM 143.1m / Interest Expense TTM 0.0)
EV/FCF = 27.06x (Enterprise Value 2.98b / FCF TTM 110.3m)
FCF Yield = 3.70% (FCF TTM 110.3m / Enterprise Value 2.98b)
FCF Margin = 11.51% (FCF TTM 110.3m / Revenue TTM 958.5m)
Net Margin = 11.51% (Net Income TTM 110.3m / Revenue TTM 958.5m)
Gross Margin = 24.29% ((Revenue TTM 958.5m - Cost of Revenue TTM 725.7m) / Revenue TTM)
Gross Margin QoQ = 25.35% (prev 23.31%)
Tobins Q-Ratio = 4.64 (Enterprise Value 2.98b / Total Assets 643.0m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 28.1m)
Taxrate = 22.91% (32.8m / 143.1m)
NOPAT = 110.3m (EBIT 143.1m * (1 - 22.91%))
Current Ratio = 2.03 (Total Current Assets 462.3m / Total Current Liabilities 228.1m)
Debt / Equity = 0.07 (Debt 28.1m / totalStockholderEquity, last quarter 394.2m)
Debt / EBITDA = -1.17 (Net Debt -205.0m / EBITDA 174.7m)
Debt / FCF = -1.86 (Net Debt -205.0m / FCF TTM 110.3m)
Total Stockholder Equity = 368.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 18.56% (Net Income 110.3m / Total Assets 643.0m)
RoE = 29.92% (Net Income TTM 110.3m / Total Stockholder Equity 368.8m)
RoCE = 36.75% (EBIT 143.1m / Capital Employed (Equity 368.8m + L.T.Debt 20.7m))
RoIC = 29.47% (NOPAT 110.3m / Invested Capital 374.4m)
WACC = 7.08% (E(3.19b)/V(3.22b) * Re(7.14%) + D(28.1m)/V(3.22b) * Rd(0.0%) * (1-Tc(0.23)))
Discount Rate = 7.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -44.95 | Cagr: -0.59%
[DCF] Terminal Value 77.97% ; FCFF base≈102.8m ; Y1≈117.8m ; Y5≈173.4m
[DCF] Fair Price = 55.18 (EV 2.61b - Net Debt -205.0m = Equity 2.81b / Shares 51.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -82.95 | EPS CAGR: -26.32% | SUE: N/A | # QB: 0
Revenue Correlation: 99.28 | Revenue CAGR: 10.82% | SUE: N/A | # QB: 0